Are the insulin-like growth factors relevant to cancer?

This publication has 54 references indexed in Scilit:

• Identification of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 as Signaling Intermediates in the α6β4 Integrin-Dependent Activation of Phosphoinositide 3-OH Kinase and Promotion of Invasion
  Molecular and Cellular Biology, 2001
• Etanercept (Enbrel): update on therapeutic use
  Annals of the Rheumatic Diseases, 2000
• Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
  JNCI Journal of the National Cancer Institute, 2000
• Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism
  Oncogene, 1999
• Circulating concentrations of insulin-like growth factor I and risk of breast cancer
  The Lancet, 1998
• Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)
  European Journal Of Cancer, 1993
• Recombinant insulin‐like growth factor binding protein‐1 inhibits IGF‐I, serum, and estrogen‐dependent growth of MCF‐7 human breast cancer cells
  Journal of Cellular Physiology, 1993
• Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour
  Nature, 1993
• Regulation of Insulin-Like Growth Factor-Binding Protein (IGFBP) Expression by Breast Cancer Cells: Use of IGFBP-1 as as Inhibitor of Insulin-like Growth Factor Action
  JNCI Journal of the National Cancer Institute, 1992
• ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
  The Lancet, 1896